MiMi P. Macias

An in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter.

MiMi P. Macias, Mark F. Stinski · Proceedings of the National Academy of Sciences · 1993 · 109 citations · Full text

Viral Replication, Bacterial Fusion Protein, Immunology +20

Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice

MiMi P. Macias, Lorraine A. Fitzpatrick, Ina E. Brenneise et al. · Journal of Clinical Investigation · 2001 · 70 citations · Full text

Immunology, Transgenic Marrow, Transgenic Mice +17

Molecular Differences and Similarities between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis

Chera L. Maarouf, Tyler A. Kokjohn, Charisse M. Whiteside et al. · Biochemistry Insights · 2013 · 64 citations · Full text

Transgenic Mouse Models, Immunology, Neurochemical Biomarkers +24

Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial

Boris Decourt, Denise Drumm-Gurnee, Jeffrey R. Wilson et al. · Current Alzheimer Research · 2017 · 52 citations · Full text

Cellular or viral protein binding to a cytomegalovirus promoter transcription initiation site: effects on transcription

MiMi P. Macias, Liping Huang, Philip Lashmit et al. · Journal of Virology · 1996 · 40 citations · Full text

Ie2 Protein, Transcriptional Regulation, Viral Protein +14